Genetics: Analysis and Principles
6th Edition
ISBN: 9781259616020
Author: Robert J. Brooker Professor Dr.
Publisher: McGraw-Hill Education
expand_more
expand_more
format_list_bulleted
Concept explainers
Videos
Textbook Question
Chapter 22.5, Problem 2COMQ
Which of the following best describes the approach that was used in the first gene therapy trial for treating SCID?
a. The normal ADA gene was introduced by injecting liposomes directly into the patients’ bodies.
b. Lymphocytes were removed from a SCID patient, the normal ADA gene was transferred into the lymphocytes via liposomes, and then the lymphocytes were returned to the patient’s body.
c. Lymphocytes were removed from a SCID patient, the normal ADA gene was transferred into the lymphocytes via a retrovirus, and then the lymphocytes were returned to the patient’s body.
d. None of the above describe the approach used in the trial.
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solution
Students have asked these similar questions
In relation to immunotechnology, answer the following:
A- Answer the following in relation to Hybridoma technology:
→ What is the cancer cell line name used in hybridoma technology?
→ Give an example of murine Monocolonal Antibody produced by hybridoma technology?
B- Give ONE main difference between: Murine MABs and fully human MABs?
and explain the reason behind developing different forms of Monoclonal antibodies (chimeric MABs, humanized MABs, and fully human MABs)
C- You are in an internship in one major Hospital, You were in rotation with a clinical pharmacist in oncology section and you came over a breast cancer patient. The personal doctor was making a quick visit to the patient to make sure the patient is following the therapeutic protocol and the treatment is running smoothly. The doctor wrote in the prescription sheet “Trastuzumab” to be dispensed by the In Patient Pharmacy, when the clinical pharmacist saw this he advised the doctor politely to use the…
Flow cytometry analysis was performed on the blood of an individual known to have been recently exposed to both rhinovirus (RV) and Mycobacterium tuberculosis (M.tb; an intracellular bacterial pathogen). Although an effective T cell response against RV was detected, a T cell response against M.tb was absent. Subsequently, genetic testing was performed, and the individual was found to possess two mutations. Below, indicate the MOST LIKELY mutations.
A. T-bet; IL-12
B. CD28: IL-2Ra
C. RORyT: IL-17
D. CD3: CD4
Which of the following is the most likely explanation for an individual who lacks CCR5 as a result of a homozygous defect in the CCR5 gene becoming infected with HIV?
a. The mutated CCR5 genes reverted to the normal form, rendering macrophages susceptible to macrophagetropic HIV variants.
b. The macrophage-tropic HIV variant entered host cells using CD4 alone.
c. The viral nucleic acid alone was taken up by cells, as in cell transformation by bacterial DNA.
d. The individual had received a transplant of HIV-infected cells expressing normal CCR5.
e. The primary infection involved a lymphocyte-tropic strain of HIV that used CXCR4 as its co-receptor.
Chapter 22 Solutions
Genetics: Analysis and Principles
Ch. 22.1 - 1. Which of the following uses of microorganisms...Ch. 22.1 - Prob. 2COMQCh. 22.1 - Prob. 3COMQCh. 22.2 - When a cloned gene is inserted into a noncritical...Ch. 22.2 - Prob. 2COMQCh. 22.3 - Prob. 1COMQCh. 22.3 - Prob. 2COMQCh. 22.4 - Prob. 1COMQCh. 22.4 - Prob. 2COMQCh. 22.5 - A means of introducing a cloned gene into cells...
Ch. 22.5 - 2. Which of the following best describes the...Ch. 22 - 1. What is a recombinant microorganism? Discuss...Ch. 22 - Prob. 2CONQCh. 22 - 3. What is bioremediation? What is the difference...Ch. 22 - Prob. 4CONQCh. 22 - Prob. 5CONQCh. 22 - Prob. 6CONQCh. 22 - 7. What is a transgenic organism? Describe three...Ch. 22 - Prob. 8CONQCh. 22 - Explain the difference between gene modification...Ch. 22 - As described inChapter 5, not all inherited traits...Ch. 22 - Prob. 11CONQCh. 22 - 12. Discuss the concerns that some people have...Ch. 22 - Prob. 1EQCh. 22 - 2. Bacillus thuringiensis makes toxins that kill...Ch. 22 - Prob. 3EQCh. 22 - Prob. 4EQCh. 22 - Prob. 5EQCh. 22 - What is a gene knockout? Is an animal or plant...Ch. 22 - Prob. 7EQCh. 22 - Evidence [see P. G. Shiels, A. J. Kind, K. H....Ch. 22 - Prob. 9EQCh. 22 - 10. What is reproductive cloning? Are identical...Ch. 22 - Researchers have identified a gene in humans that...Ch. 22 - Treatment of adenosine deaminase (ADA) deficiency...Ch. 22 - Several research studies are under way that...Ch. 22 - Prob. 1QSDCCh. 22 - 2. A commercially available strain of P....Ch. 22 - Prob. 3QSDC
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Similar questions
- Which of the following can be answered by immunohistochemistry? Select all that apply. a. Whether BDNF binds to NF200 b. Whether transcription occurs in GFAP- expressing cells c. Whether BDNF is found in GFAP-expressing cells d. Whether newly transcribed BDNF MRNA is detectable in a tissue slicearrow_forwardWhich of the following is a concern of in-vivo gene therapy? A. Lytic vector expression B. Integration into target region C. Immune response to viral vector D. Production of chimeraarrow_forwardWhich technique allows the recovery of a protein from a sample such that the recovered protein can be used in subsequent experiments? a. monoclonal antibody cocktail b. enzyme-linked immunosorbent assay c. Western blot d. Southern blot e. immunoprecipitation I thought the answer is western blot but I got it wrong.. Would the answer be immunoprecipitation? I really have no idea please help..arrow_forward
- he "Vaccine Options" figure, under the "Antibody Preparation" heading, the term "antigen" is ed. Which option most closely matches the definition of the term "antigen"? A). A single, whole particle of the COVID-19 virus. B). A piece of the COVID-19 virus used by the body to recognize infection. C). An immune cell designed to remember the virus at a later point of infection. D). An immune cell designed to destroy virus infected cells.arrow_forwardWhat is the predicted outcome if a patient receives an allogeneic hematopoietic cell transplant from a family member, and then receives a kidney transplant several months later from the same donor? a. Acute kidney rejection because the patient’s hematopoietic system has been fully reconstituted with patient-derived alloreactive T cells and NK cells. b. Graft-versus-host disease mediated by alloreactive T cells in the transplanted kidney. c. Secondary immune response by patient-derived memory T lymphocytes that were initially activated by the hematopoietic cell transplant. d. The patient is tolerant to alloantigens on the kidney graft and does not require long-term immunosuppressive drugs.arrow_forwardWhat is unique about the use of viral gene therapy in cancer immunotherapy that allows it to be safe where it wouldn’t safe against something like sickle cell anemia? Please answer in short and ASAP .arrow_forward
- How we can Treatment Severe Combined Immunodeficiency (SCID) by using gene therapy? Please answer at your own words,please..arrow_forwardThank you. The expert seems made a typo. The correct answer should be "(f) sample B has more Ras protein", instead of (d).arrow_forwardExplain the difference in results for the RT-PCR from the CD4+ T cells and the RT-PCR from the CD8+T cells. (i.e., propose a conclusion)arrow_forward
- Which of the following statements best explains why the immune system can continue to make antibodies after treatment with the anti-CD20 antibody rituximab? a. New CD20-positive B cells are reconstituted so quickly that antibody concentration during and after treatment is unaffected. b. Rituximab stimulates B-cell proliferation, so for a short while after its administration there is actually an increase in antibody concentration. c. Rituximab is a mouse monoclonal antibody and therefore its Fc region is unable to bind to the surface d. Plasma cells do not express CD20 on their cell surface, and antibody production by these cells continues unhampered. e. Rituximab stimulates anti-antibody production, leading to its rapid clearance by the body.arrow_forwardWe now have at least three SARS-CoV-2/COVID-19 vaccines approved by the FDA for use in the United States. These vaccines cause cells in the body to make the spike protein that is on the surface of the virus, and subsequently, stimulate an antibody response to this antigen. A. What do these antibodies do to prevent infection by SARS-CoV-2? How do they interact with the virus particles? B. Which kind of cells in the immune system are responsible for synthesizing these antibodies?arrow_forwardA plaque assay is an effective way to determine the concentration of lysogenic phage in a solution. A. True B. Falsearrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)BiologyISBN:9780134580999Author:Elaine N. Marieb, Katja N. HoehnPublisher:PEARSON
Biology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStax
Anatomy & PhysiologyBiologyISBN:9781259398629Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa StouterPublisher:Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)BiologyISBN:9780815344322Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter WalterPublisher:W. W. Norton & Company
Laboratory Manual For Human Anatomy & PhysiologyBiologyISBN:9781260159363Author:Martin, Terry R., Prentice-craver, CynthiaPublisher:McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)BiologyISBN:9781260231700Author:Sylvia S. Mader, Michael WindelspechtPublisher:McGraw Hill Education
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:PEARSON
Biology 2e
Biology
ISBN:9781947172517
Author:Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:OpenStax
Anatomy & Physiology
Biology
ISBN:9781259398629
Author:McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:9780815344322
Author:Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:9781260159363
Author:Martin, Terry R., Prentice-craver, Cynthia
Publisher:McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Biology
ISBN:9781260231700
Author:Sylvia S. Mader, Michael Windelspecht
Publisher:McGraw Hill Education
What is cancer? What causes cancer and how is it treated? *UPDATE*; Author: Cancer Treatment Centers of America - CTCA;https://www.youtube.com/watch?v=_N1Sk3aiSCE;License: Standard Youtube License